Stock options

Elon Musk has voiced concerns about losing control of Tesla, citing his current 12.8% stake as insufficient to secure his position, especially with the company’s future robotics focus. He refuted claims of using Tesla stock as loan collateral. Musk aims for a 25% share to maintain strategic influence, highlighting the impact of stock option taxation on his voting control. His apprehension stems from the possibility of being ousted by activist shareholders after Tesla produces “millions of robots.”

Tesla has filed paperwork revealing a potential $29 billion stock option package for CEO Elon Musk. This “interim award” aims to secure Musk’s leadership as Tesla shifts towards autonomous vehicles and robotics. The move follows a Delaware court’s rescission of Musk’s 2018 compensation plan, now under appeal. The new grant, structured to avoid double compensation, would increase Musk’s stake in Tesla if the Delaware ruling stands and he remains an executive for two years. Analysts view it as a signal of confidence in Musk’s ability to guide Tesla’s strategic evolution.

Sierra Madre Gold and Silver (SMDRF) granted 2,750,000 stock options at $0.73 per share to employees, directors, management, and consultants. The options have a five-year exercise window. Vesting for most options occurs in three stages: one-third immediately, one-third after six months, and the final third after twelve months. 40,000 options are allocated to Adelaide Capital, vesting quarterly over a year. The grant awaits TSX Venture Exchange approval.

DMG Blockchain Solutions reported June 2025 operational results, detailing a decrease in Bitcoin mined and hashrate due to electrical outages and hydroelectric infrastructure issues. The company plans to use alternative manufacturers for new hydro operations and is developing a pilot system to reach 3 EH/s by year-end. DMG also announced a new Canadian data processing center agreement. Stock options and RSUs were granted to employees and directors.

IDEAYA Biosciences announced stock option grants to a new employee. The company awarded 95,600 shares at $22.29 per share under its 2023 plan, aiming to attract talent. Options vest over four years, with 25% vesting after the first year. IDEAYA, a precision medicine oncology company, focuses on targeted therapies based on molecular diagnostics and synthetic lethality approaches.

Empress Royalty Corp. (EMPR) announced strategic moves to incentivize key personnel. The company granted 1,400,000 stock options at $0.68, vesting over three years, and 1,750,000 restricted share units (RSUs) and 650,000 deferred share units (DSUs), vesting over two years. These initiatives aim to align employee interests with long-term shareholder value, demonstrating Empress’ commitment to rewarding performance and fostering a culture of ownership. Empress focuses on gold and silver investments using royalty and streaming models.

Forte Minerals Corp. (FOMNF) approved 225,000 stock options for directors, officers, and consultants, exercisable at $0.475/share with a five-year term and compliance with CSE’s four-month restricted holding period. The grant aligns management incentives with long-term shareholder value, signaling internal stability in copper exploration amid rising demand. Analysts caution potential dilution risks from conversions but highlight its strategic position through Peruvian partnerships, balancing growth opportunities with regulatory adherence.